Исследование эффективности Витрум® Мемори (Vitrum® memory) при сухой форме возрастной макулодистрофии и глаукоме

The study was conducted to assess clinical efficacy of VITRUM ®MEMORY in therapeutic dosage for 3 months in patients with glaucoma and dry form of age-related macular degeneration (AMD). Survey data, visual acuity, biomicroscopy, computer perimetry, electrophysiological studies (EPS): visual evoked potentials (VEP) and pattern electroretinogram (pattern ERG), HRT3 and OCT were evaluated. Therapeutic treatment with medication under investigation revealed improvement in the subjective state, reduction of visual and mental fatigue, increased light sensitivity, as well as statistically significant improvement in visual function (for computer perimetry and EPS).